ISCRM’s Innovation Pilot Award (IPA) program, supported by resources from the State of Washington, aims to support innovative research of any current UW FACULTY member of ISCRM (Acting, Research and Regular Faculty) who is pursuing novel experiments that are directly relevant to stem cell biology or regeneration. The applicant needs to state how IPA support will enable the research to advance to the point of being competitive for external funding. The IPA program is not intended to extend currently funded research but instead will fund new research projects. Collaborations that involve two or more laboratories are encouraged but all applications will be considered.
Applications for the Innovation Pilot Awards are closed and will reopen Spring 2020. Instructions on how to apply can be found here.
The John H. Tietze Stem Cell Scientist Award is a one-year award of $50,000 to support the research of any UW FACULTY member of ISCRM who is pursuing novel preliminary experiments, where the grant might provide sufficient stimulus to enable the research to advance to the point of being competitive for external funding. The research should involve or be relevant to some aspect of stem or progenitor cell biology or therapies.
The Jaconette L. Tietze Young Scientist Award is also for one year of support of $25,000. Preference will be given a junior faculty (including Acting Instructor level) located at the UW who has not yet received major external funding (such as an R01). The research should involve or be relevant to some aspect of stem or progenitor cell biology or therapies.
Applications for the Tietze Research Awards are now closed. Instructions on how to apply can be found here.
For a list of previous awardees, click here.
Scientists and Principal Investigators across the University are invited to apply for a Quellos Research Acceleration Awards, which will be awarded competitively in varying amounts to pay for pilot projects utilizing high throughput screening. It is the intent of these awards to provide University investigators access to high throughput screening in order to generate sufficient preliminary data that award recipients can use as preliminary results in future grant applications, as well as establish proof of concept data for expanded screens. These awards, and the Quellos High Throughput Screening Core (i.e., QHTS Core), are operated by the Institute for Stem Cell and Regenerative Medicine at the South Lake Union campus of UW Medicine.
Instructions on how to apply can be found here.